GUARNERI, VALENTINA

GUARNERI, VALENTINA  

Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG  

Mostra records
Risultati 1 - 20 di 414 (tempo di esecuzione: 0.055 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
A 3D morphogenetic blueprint for metastatic outgrowth in breast cancer 2026 Caire, RobinZanconato, FrancescaPanciera, TitoAudoux, EstelleContessotto, PaoloRomano, OrianaSuli, AmbelaBattilana, GiusyMarchionni, MatteoDieci, Maria VittoriaGriguolo, GaiaFassan, MatteoGuzzardo, VincenzaDei Tos, Angelo PaoloBicciato, SilvioGuarneri, ValentinaCordenonsi, Michelangelo + CELL - -
CHIMERA: A Phase II Study of Neoadjuvant Pembrolizumab in Combination With Cisplatin or Carboplatin and Pemetrexed Followed by Surgery and Adjuvant Pembrolizumab in Resectable Pleural Mesothelioma 2026 Pasello, GiuliaScattolin, DanielaFaccioli, EleonoraMarulli, GiuseppePezzuto, FedericaCalabrese, FiorellaGuarneri, ValentinaDell'Amore, AndreaRea, Federico + CLINICAL LUNG CANCER - -
Concomitant radiation therapy and trastuzumab deruxtecan in metastatic breast cancer: feasibility, safety, and outcomes from a real-life multicentre international cohort 2026 Griguolo, GaiaGuarneri, Valentina + THE BREAST - -
Costs of breast cancer care by stage and HER-2 Status: a population-based study 2026 Buja, AlessandraGuarneri, Valentina + FRONTIERS IN HEALTH SERVICES - -
Dissecting the prognostic role of metabolic markers in lung neuroendocrine Tumors: The MONET study 2026 Pasello, GiuliaPigato, GiuliaPezzuto, FedericaScattolin, DanielaMaso, Alessandro DalBonanno, LauraCalabrese, FiorellaDell'Amore, AndreaGuarneri, ValentinaIndraccolo, Stefano + LUNG CANCER - -
Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2 2026 Dieci, Maria VittoriaMenichetti, AliceGriguolo, GaiaGuarneri, ValentinaMariani, Luigi + THE BREAST - -
Evolution of ER-cut-off definition in clinical trials for triple negative breast cancer: trends and patterns over 15 years 2026 Bonomi, GiorgioGriguolo, GaiaLando, StefaniaMassa, DavideGuarneri, ValentinaDieci, Maria Vittoria + THE BREAST - -
Integrating PIK3CA Testing into Clinical Practice for Advanced HR+/HER2- Breast Cancer: An Expert Consensus 2026 Guarneri, Valentina + THE BREAST - -
Long-term outcome of isolated locoregional (ILRR) breast cancer (BC) recurrence: a large retrospective Mono-institutional study 2026 Griguolo, GaiaMenichetti, AliceGuarneri, ValentinaDieci, Maria Vittoria + THE ONCOLOGIST - -
Multidisciplinary approach to bone metastases: a single center experience in a tertiary cancer center 2026 Krengli, MarcoAngelini, AndreaGuarneri, Valentina + SUPPORTIVE CARE IN CANCER - -
Pleomorphic and florid lobular carcinoma in situ of the Breast: A systematic review of current evidence and knowledge gaps 2026 Passeri, DanieleGuarneri, ValentinaDei Tos, Angelo Paolo + THE BREAST - -
Proactive Brain Screening Using Contrast-Enhanced Brain CT Scans in HER2+ Metastatic Breast Cancer 2026 Gaia GriguoloMichele BottossoGiorgio BonomiFederica MigliettaMaria Vittoria DieciValentina Guarneri + CLINICAL CANCER RESEARCH - -
Rational adjustment of dose to reduce adverse reactions (RADAR) in patients with platinum-sensitive recurrent ovarian cancer: Results from the phase II NEWTON trial (ENGOT-ov49) 2026 Tasca, GiuliaGuarneri, ValentinaMassa, Davide + EUROPEAN JOURNAL OF CANCER - -
Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study 2026 Dieci, Maria VittoriMenichetti, AliceGriguolo, GaiaGuarneri, ValentinaMariani, Luigi + BREAST - -
Role of ctDNA in predicting the outcome of patients with hormone receptor-positive, HER2-negative advanced breast cancer treated with first-line ribociclib and letrozole: BioItaLEE trial 2026 Guarneri, Valentina + CLINICAL CANCER RESEARCH - -
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer 2026 Guarneri, Valentina + THE NEW ENGLAND JOURNAL OF MEDICINE - -
Standardized Analytical Verification of ctDNA ESR1 Mutation Testing in Metastatic HR+/HER2- Breast Cancer: A European Multicentre Study Using dPCR and NGS-Based Liquid Biopsy 2026 Guarneri, ValentinaIndraccolo, Stefano + MOLECULAR DIAGNOSIS & THERAPY - -
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer 2026 Guarneri, Valentina + THE NEW ENGLAND JOURNAL OF MEDICINE - -
A-BRAVE trial: a phase III randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patients 2025 Dieci, M. V.Guarneri, V. + ANNALS OF ONCOLOGY - -
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy 2025 Miglietta, FedericaDieci, Maria VittoriaGuarneri, Valentina + NPJ BREAST CANCER - -